SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity

Detalles Bibliográficos
Autores principales: Anft, Moritz, Paniskaki, Krystallenia, Giglio, Tina, Wellenkötter, Jacqueline, Blazquez-Navarro, Arturo, Meister, Toni L., Roch, Toralf, Giesecke-Thiel, Claudia, Westhoff, Timm H., Stervbo, Ulrik, Pfaender, Stephanie, Cinkilic, Okan, Babel, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624106/
https://www.ncbi.nlm.nih.gov/pubmed/36332726
http://dx.doi.org/10.1016/j.kint.2022.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624106/
https://www.ncbi.nlm.nih.gov/pubmed/36332726
http://dx.doi.org/10.1016/j.kint.2022.10.012

Ejemplares similares